931 related articles for article (PubMed ID: 30545971)
1. Risk stratification and medical therapy of pulmonary arterial hypertension.
Galiè N; Channick RN; Frantz RP; Grünig E; Jing ZC; Moiseeva O; Preston IR; Pulido T; Safdar Z; Tamura Y; McLaughlin VV
Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545971
[TBL] [Abstract][Full Text] [Related]
2. Ensuring appropriate access to pulmonary arterial hypertension therapy.
Highland KB; Hughes KE; Williams KJ; Kyei-Baffour B; Ferguson S
Am J Manag Care; 2019 Jun; 25(7 Suppl):S119-S127. PubMed ID: 31318517
[TBL] [Abstract][Full Text] [Related]
3. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
Hansmann G; Apitz C
Heart; 2016 May; 102 Suppl 2():ii67-85. PubMed ID: 27053700
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary arterial hypertension.
Boucly A; Gerges C; Savale L; Jaïs X; Jevnikar M; Montani D; Sitbon O; Humbert M
Presse Med; 2023 Sep; 52(3):104168. PubMed ID: 37516248
[TBL] [Abstract][Full Text] [Related]
5. Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.
Badagliacca R; D'Alto M; Ghio S; Argiento P; Bellomo V; Brunetti ND; Casu G; Confalonieri M; Corda M; Correale M; D'Agostino C; De Michele L; Galgano G; Greco A; Lombardi C; Manzi G; Mercurio V; Mulè M; Paciocco G; Papa S; Romeo E; Scelsi L; Stolfo D; Vitulo P; Naeije R; Vizza CD
Am J Respir Crit Care Med; 2021 Feb; 203(4):484-492. PubMed ID: 32857597
[No Abstract] [Full Text] [Related]
6. Management of Pulmonary Arterial Hypertension.
Weatherald J; Varughese RA; Liu J; Humbert M
Semin Respir Crit Care Med; 2023 Dec; 44(6):746-761. PubMed ID: 37369218
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary hypertension: definition, classification and treatments].
Jutant EM; Humbert M
Biol Aujourdhui; 2016; 210(2):53-64. PubMed ID: 27687597
[TBL] [Abstract][Full Text] [Related]
8. Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension.
Lange TJ
Herz; 2023 Aug; 48(4):259-265. PubMed ID: 37085727
[TBL] [Abstract][Full Text] [Related]
9. Advances in targeted therapy for pulmonary arterial hypertension in children.
Li L; Zhu X; Chen X; Gao J; Ding C; Zhang M; Ma S
Eur J Pediatr; 2023 May; 182(5):2067-2076. PubMed ID: 36527480
[TBL] [Abstract][Full Text] [Related]
10. Medical Treatment of Pulmonary Arterial Hypertension.
Sahay S; Humbert M; Sitbon O
Semin Respir Crit Care Med; 2017 Oct; 38(5):686-700. PubMed ID: 29032569
[No Abstract] [Full Text] [Related]
11. Management of Pulmonary Arterial Hypertension in the Pediatric Patient.
Ezekian JE; Hill KD
Curr Cardiol Rep; 2019 Nov; 21(12):162. PubMed ID: 31781972
[TBL] [Abstract][Full Text] [Related]
12. Current and advancing treatments for pulmonary arterial hypertension in childhood.
Zijlstra WM; Ploegstra MJ; Berger RM
Expert Rev Respir Med; 2014 Oct; 8(5):615-28. PubMed ID: 25047735
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary arterial hypertension from the risk assessment to combined treatment].
Santos-Martínez LE; Moreno-Ruiz LA; Cabrera-Ramírez C; Mendoza-Pérez BC; Galván-Oseguera H; Magaña-Serrano JA; Lupercio-Mora K; Saturno-Chiu G
Rev Med Inst Mex Seguro Soc; 2019 Sep; 57(5):314-323. PubMed ID: 32568487
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension: A Meta-analysis of Randomized Controlled Trials.
Liu HL; Chen XY; Li JR; Su SW; Ding T; Shi CX; Jiang YF; Zhu ZN
Chest; 2016 Aug; 150(2):353-66. PubMed ID: 27048870
[TBL] [Abstract][Full Text] [Related]
15. [Targeted therapy for pulmonary arterial hypertension in patients without comorbidities].
Klose H; Harbaum L; Richter MJ; Lichtblau M; Marra AM; Kabitz HJ; Harutyunova S; Milger-Kneidinger K; Lange TJ
Pneumologie; 2023 Nov; 77(11):890-900. PubMed ID: 37963478
[TBL] [Abstract][Full Text] [Related]
16. Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
Berlier C; Schwarz EI; Saxer S; Lichtblau M; Ulrich S
Lung; 2019 Jun; 197(3):353-360. PubMed ID: 30963265
[TBL] [Abstract][Full Text] [Related]
17. Medical therapies for pulmonary arterial hypertension.
Pulido T; Zayas N; de Mendieta MA; Plascencia K; Escobar J
Heart Fail Rev; 2016 May; 21(3):273-83. PubMed ID: 26791159
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.
Hoeper MM; Apitz C; Grünig E; Halank M; Ewert R; Kaemmerer H; Kabitz HJ; Kähler C; Klose H; Leuchte H; Ulrich S; Olsson KM; Distler O; Rosenkranz S; Ghofrani HA
Int J Cardiol; 2018 Dec; 272S():37-45. PubMed ID: 30190158
[TBL] [Abstract][Full Text] [Related]
19. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives.
Zheng W; Wang Z; Jiang X; Zhao Q; Shen J
J Med Chem; 2020 Dec; 63(24):15153-15186. PubMed ID: 33314936
[TBL] [Abstract][Full Text] [Related]
20. Recent strategies in treatment of pulmonary arterial hypertension, a review.
Fallah F
Glob J Health Sci; 2015 Jan; 7(4):307-22. PubMed ID: 25946920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
